Categories: News

THE WORLD’S 50 BEST BARS UNVEILS LIST OF BARS RANKED FROM 51-100

LONDON, Sept. 24, 2025 /PRNewswire/ — With two weeks to go until The World’s 50 Best Bars 2025, sponsored by Perrier, the bars ranked from No.51 to No.100 have been revealed for the ninth year. The annual list is created by votes from more than 800 independent experts, including bartenders, educators and drinks writers.

- Advertisement -
  • The 51-100 list includes bars spanning 34 different cities across the world
  • There are 16 new entries on the list, ranging from São Paulo and San Francisco to Barcelona and New Delhi
  • Two cities feature for the first time: Taichung and Medellín
  • USA leads with eight bars from across Chicago, Los Angeles, Miami, New York and San Francisco
  • Europe leads the way with 15 bars on the list
  • The 51-100 list includes 12 bars in Asia

Returning to Asia for its 17th annual edition, The World’s 50 Best Bars 2025 will gather the global drinks industry in Hong Kong in celebration of the finest cocktail experiences worldwide. With the 51-100 list, 50 Best continues to shine a light on an even wider array of remarkable bars and cocktail destinations, amplifying its recognition of excellence on a global scale.

- Advertisement -

New entries for 2025 include Mexico City’s Bar Mauro (No.54), New York’s Schmuck (No.59), São Paulo’s Exímia (No.61), San Francisco’s True Laurel (No.64), Hong Kong’s Gokan (No.70), Taichung’s Vender (No.74), London’s Three Sheets Soho (No.80), Medellín’s Mamba Negra (No.81) and Bar Carmen (No.100), Buenos Aires’ Victor Audio Bar (No.87), Bangkok’s Dry Wave Cocktail Studio (No.88) and Opium (No.92), Barcelona’s Foco (No.89), Los Angeles’ Mírate (No.93), New Delhi’s Lair (No.96) and Florence’s Gucci Giardino (No.99).

- Advertisement -

The full list can be viewed here.

- Advertisement -

Emma Sleight, Head of Content for The World’s 50 Best Bars, says: “The extended 51-100 list is another opportunity to celebrate the passion, creativity and world-class hospitality that define the very best in the business. Today, we raise a glass to those venues that go above and beyond, offer congratulations to the incredible teams whose hard work has earned their bar a spot on this prestigious list and hope it encourages more people to discover their next drinking destination.”

- Advertisement -

The World’s 50 Best Bars 2025 will be livestreamed on the 50 Best YouTube channel here at 20.00 Hong Kong time on 8 October 2025.

- Advertisement -

Media centre: 
http://mediacentre.theworlds50best.com/ 

- Advertisement -

Photo – https://mma.prnewswire.com/media/2774051/TW50BB2025_results_Infographic.jpg
Logo – https://mma.prnewswire.com/media/2774050/50_Best_Bars_2025_Logo.jpg

- Advertisement -

 

- Advertisement -

 

- Advertisement -

View original content:https://www.prnewswire.co.uk/news-releases/the-worlds-50-best-bars-unveils-list-of-bars-ranked-from-51-100-302564656.html

- Advertisement -

Recent Posts

Ocular Therapeutix Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

February 06, 2026 16:01 ET  | Source: Ocular Therapeutix, Inc. BEDFORD, Mass., Feb. 06, 2026…

6 hours ago

NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

February 06, 2026 16:01 ET  | Source: NewAmsterdam Pharma N.V. NAARDEN, The Netherlands and MIAMI,…

6 hours ago

Novartis breaks ground on new global Biomedical Research center in San Diego to accelerate drug discovery

New facility will enable end‑to‑end discovery across key disease areas and technology platforms, joining existing…

6 hours ago

The Ministry of Finance and the International Monetary Fund to launch tomorrow the second edition of the AlUla Conference for Emerging Market Economies

AlUla, Saudi Arabia, Feb. 7, 2026 /PRNewswire/ -- The second edition of the AlUla Conference…

6 hours ago

Roches fenebrutinib is the first investigational medicine in over a decade that reduces disability progression in primary progressive multiple sclerosis (PPMS)

Late-breaking Phase III FENtrepid results presented at ACTRIMS show investigational fenebrutinib met its primary endpoint…

6 hours ago

Lexicon Announces Closing of Approximately $94.6 Million Public Offering and Concurrent Private Placement

February 06, 2026 17:17 ET  | Source: Lexicon Pharmaceuticals, Inc. THE WOODLANDS, Texas, Feb. 06,…

6 hours ago